Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry
β Scribed by Gunnar Juliusson
- Book ID
- 119218706
- Publisher
- Elsevier
- Year
- 2011
- Tongue
- English
- Weight
- 545 KB
- Volume
- 11
- Category
- Article
- ISSN
- 2152-2650
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## METHODS. Minimum follow-up of 21.6 years for living patients was obtained for 26 patients who received weekly cytarabine and 6-thioguanine maintenance ther-2 University of Minnesota, Minneapolis, Minneapy after achieving complete remission (CR) in the UMMCC study. Minimum sota. follow-up of 7.
## Abstract ## BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, but outcome is hampered by toxicity. Populationβbased data avoid patient selection and may therefore substitute for lack of randomized trials. ## METHODS: We evaluated alloSCT rates